Acadian Asset Management
PRAH

Acadian Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Acadian Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,276
Closed -$502K – 2324
2021
Q1 		$502K Sell
3,276
-94,961
-97% -$12.9M ﹤0.01% 1195
2020
Q4 		$12.3M Buy
98,237
+962
+1% +$108K 0.05% 300
2020
Q3 		$9.87M Buy
97,275
+6,889
+8% +$702K 0.04% 317
2020
Q2 		$8.79M Buy
90,386
+11,780
+15% +$1.1M 0.04% 352
2020
Q1 		$6.53M Sell
78,606
-106,837
-58% -$10.4M 0.04% 341
2019
Q4 		$20.6M Sell
185,443
-136,574
-42% -$14M 0.09% 201
2019
Q3 		$32M Buy
+322,017
New +$32M 0.14% 154
2019
Q2 		– Sell
-665,643
Closed -$73.4M – 2135
2019
Q1 		$73.4M Buy
665,643
+9,202
+1% +$962K 0.32% 83
2018
Q4 		$60.4M Sell
656,441
-276,455
-30% -$28M 0.3% 94
2018
Q3 		$103M Sell
932,896
-79,362
-8% -$8.26M 0.42% 65
2018
Q2 		$94.5M Sell
1,012,258
-303,990
-23% -$26.2M 0.41% 69
2018
Q1 		$109M Sell
1,316,248
-165,349
-11% -$14.7M 0.47% 58
2017
Q4 		$135M Sell
1,481,597
-325,471
-18% -$27.1M 0.59% 47
2017
Q3 		$138M Sell
1,807,068
-146,308
-7% -$11.1M 0.61% 41
2017
Q2 		$147M Sell
1,953,376
-199,640
-9% -$13.8M 0.66% 37
2017
Q1 		$140M Buy
2,153,016
+7,769
+0.4% +$458K 0.64% 35
2016
Q4 		$118M Sell
2,145,247
-207,986
-9% -$11.4M 0.57% 41
2016
Q3 		$133M Buy
2,353,233
+22,690
+1% +$1.11M 0.66% 36
2016
Q2 		$97.3M Buy
2,330,543
+1,125,077
+93% +$51.8M 0.5% 64
2016
Q1 		$51.5M Buy
1,205,466
+754,357
+167% +$31.9M 0.26% 109
2015
Q4 		$20.4M Buy
451,109
+384,137
+574% +$16.1M 0.11% 204
2015
Q3 		$2.6M Buy
66,972
+36,686
+121% +$1.47M 0.01% 507
2015
Q2 		$1.1M Buy
30,286
+22,425
+285% +$709K 0.01% 659
2015
Q1 		$227K Buy
+7,861
New +$219K ﹤0.01% 900

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Acadian Asset Management's PRAH Position: Q2 2021 in Review

Acadian Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 3,276 shares — an estimated $502K sold.

Acadian Asset Management first reported a position in PRAH in Q1 2015 and held it in 24 quarters. The position peaked at $147M in Q2 2017. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Acadian Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Acadian Asset Management sold 3,276 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $502K.
  • Acadian Asset Management first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 24 quarters.
  • Acadian Asset Management's PRA Health Sciences, Inc. position peaked at $147M in Q2 2017.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Acadian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.